Quantinno Capital Management LP Viatris Inc Transaction History

Quantinno Capital Management LP

$9.91 Billion
Q4 2024

A detailed history of Quantinno Capital Management LP transactions in Viatris Inc stock. As of the latest transaction made, Quantinno Capital Management LP holds 244,952 shares of VTRS stock, worth $2.75 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

244,952

Previous 201,359 21.65%

Holding current value

$2.75 Million

Previous $2.34 Million 30.47%

% of portfolio

0.03%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$11.32 - $13.37 $493,472 - $582,838	43,593 Added 21.65%	244,952 $3.05 Million
Q3 2024 Nov 14, 2024	BUY	$10.32 - $12.13 $1.48 Million - $1.73 Million	142,939 Added 244.67%	201,359 $2.34 Million
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $164,116 - $196,286	-16,330 Reduced 21.85%	58,420 $621,000
Q1 2024 May 14, 2024	BUY	$11.27 - $13.53 $391,474 - $469,978	34,736 Added 86.81%	74,750 $892,000
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $86,708 - $107,273	-9,887 Reduced 19.81%	40,014 $433,000
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $312,470 - $369,817	32,583 Added 188.15%	49,901 $492,000
Q2 2023 Aug 04, 2023	SELL	$9.02 - $10.29 $71,294 - $81,332	-7,904 Reduced 31.34%	17,318 $172,000
Q1 2023 May 03, 2023	SELL	$9.2 - $12.26 $288,604 - $384,596	-31,370 Reduced 55.43%	25,222 $242,000
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $397,588 - $527,078	45,595 Added 414.61%	56,592 $629,000
Q3 2022 Nov 07, 2022	SELL	$8.48 - $11.13 $262,701 - $344,796	-30,979 Reduced 73.8%	10,997 $94,000
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $417,661 - $515,045	41,976 New	41,976 $439,000

Others Institutions Holding VTRS

# of Institutions

1,135

Shares Held

986M

Call Options Held

2.34M

Put Options Held

2.21M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.6B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.

Account

Quantinno Capital Management LP Viatris Inc Transaction History